⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Sensorion and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Sensorion
↗Montpellier, France
Sensorion is a clinical-stage biotechnology company based in France, dedicated to the development of innovative therapies to restore, treat, and prevent inner ear disorders. The company operates at the intersection of audiology and precision medicine, focusing on both genetic hearing loss and acquired hearing loss conditions.
Sensorion's pipeline is built on three strategic pillars: Restore, Treat, and Prevent. The company leverages a proprietary technology platform and collaborations, notably with the Institut Pasteur, to advance its gene therapy and small-molecule programs. It is a publicly traded company listed on Euronext Paris.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Gene Therapy / Hearing Loss
SIZE & FINANCIALS
Employees:51-200
Founded:2009
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$110M+
Investors:Sanofi, Sofinnova Partners, Artal (Invus), Redmile Group, Cormorant Asset Management, Sphera Healthcare, Coastlands Capital
STOCK
Exchange:Euronext Paris
Ticker:ALSEN
Market Cap:$0.24B
PIPELINE
Stage:Phase 1/2
Lead Drug Stage:Phase 1/2 (SENS-501)
Modalities:Gene therapy, Small molecule
Active Trials:2
Trial Phases:Phase 1: 1 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Sanofi (Strategic investor and partner in gene therapy), Institut Pasteur (Scientific collaboration)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Fred Chereau - CEO
Amit Munshi - Chairman
Laurene Danon - CFO
LINKS
Website:sensorion-pharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Sensorion. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.